Innoviva, Inc. (NASDAQ:INVA – Get Rating) major shareholder Alexander J. Denner bought 50,000 shares of the company’s stock in a transaction dated Thursday, May 25th. The stock was bought at an average cost of $13.09 per share, with a total value of $654,500.00. Following the acquisition, the insider now directly owns 7,050,000 shares of the […]
Innoviva, Inc. (NASDAQ:INVA – Get Rating) major shareholder Alexander J. Denner bought 50,000 shares of the company’s stock in a transaction that occurred on Thursday, May 25th. The stock was purchased at an average price of $13.09 per share, with a total value of $654,500.00. Following the transaction, the insider now directly owns 7,050,000 shares […]
Principal Financial Group Inc. lowered its position in Innoviva, Inc. (NASDAQ:INVA – Get Rating) by 3.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 402,826 shares of the biotechnology company’s stock after selling 14,984 shares during the period. […]
Innoviva, Inc. (NASDAQ:INVA – Get Rating) major shareholder Alexander J. Denner bought 50,000 shares of the business’s stock in a transaction on Wednesday, May 17th. The shares were acquired at an average cost of $13.07 per share, with a total value of $653,500.00. Following the purchase, the insider now owns 6,954,000 shares of the company’s […]
Innoviva, Inc. (NASDAQ:INVA – Get Rating)’s stock price was up 3.3% on Tuesday following insider buying activity. The company traded as high as $13.33 and last traded at $13.33. Approximately 164,464 shares traded hands during trading, a decline of 76% from the average daily volume of 678,851 shares. The stock had previously closed at $12.91. […]